These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7763328)

  • 21. Vascular dementia today.
    Román GC
    Rev Neurol (Paris); 1999; 155 Suppl 4():S64-72. PubMed ID: 10637940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disseminated neocortical and subcortical encephalopathy (DNSE) with widespread activation of brain macrophages: a new dementia disorder? Autopsy reports of two postmenopausal women from families with mitochondrial DNA mutations.
    Haferkamp O; Rosenau W; Scheuerle A; Pietrczyk C; Skowronek P; Rödel G
    Clin Neuropathol; 1998; 17(2):85-94. PubMed ID: 9561330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular cognitive impairment.
    Selnes OA; Vinters HV
    Nat Clin Pract Neurol; 2006 Oct; 2(10):538-47. PubMed ID: 16990827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sorting out the clinical consequences of ischemic lesions in brain aging: a clinicopathological approach.
    Gold G; Kovari E; Hof PR; Bouras C; Giannakopoulos P
    J Neurol Sci; 2007 Jun; 257(1-2):17-22. PubMed ID: 17321551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Etiology and pathology of 71 dementia patients during presenile and senile periods].
    Tong Q
    Zhonghua Yi Xue Za Zhi; 1990 Aug; 70(8):431-3, 30. PubMed ID: 2174280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Vascular dementia: the dubious disease].
    Derouesné C
    Psychol Neuropsychiatr Vieil; 2005 Jun; 3(2):89-96. PubMed ID: 15929922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cognitive consequences of multiple lacunes and leukoaraiosis as vascular cognitive impairment in community-dwelling elderly individuals.
    Koga H; Takashima Y; Murakawa R; Uchino A; Yuzuriha T; Yao H
    J Stroke Cerebrovasc Dis; 2009 Jan; 18(1):32-7. PubMed ID: 19110142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymphomatosis cerebri as a cause of white matter dementia.
    Rollins KE; Kleinschmidt-DeMasters BK; Corboy JR; Damek DM; Filley CM
    Hum Pathol; 2005 Mar; 36(3):282-90. PubMed ID: 15791573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different mechanisms of corpus callosum atrophy in Alzheimer's disease and vascular dementia.
    Tomimoto H; Lin JX; Matsuo A; Ihara M; Ohtani R; Shibata M; Miki Y; Shibasaki H
    J Neurol; 2004 Apr; 251(4):398-406. PubMed ID: 15083283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular cognitive deterioration and stroke.
    Erkinjuntti T
    Cerebrovasc Dis; 2007; 24 Suppl 1():189-94. PubMed ID: 17971655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular dementia: distinguishing characteristics, treatment, and prevention.
    Román GC
    J Am Geriatr Soc; 2003 May; 51(5 Suppl Dementia):S296-304. PubMed ID: 12801386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subcortical vascular cognitive impairment: similarities and differences with multiple sclerosis.
    Schmidt R; Enzinger C; Ropele S; Schmidt H; Fazekas F
    J Neurol Sci; 2006 Jun; 245(1-2):3-7. PubMed ID: 16626755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular dementia, with special reference to its vascular and immunological events.
    Xu XH; Feng Y; Zhang XH; Liu GZ; Peng DT; Wen SG; Guo H; Zhang H; Wang H; Jiang Y; Li BL
    Alzheimer Dis Assoc Disord; 1999; 13 Suppl 3():S179-91. PubMed ID: 10609699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Degenerative and vascular lesions of the brain have synergistic effects in dementia of the elderly.
    Zekry D; Duyckaerts C; Moulias R; Belmin J; Geoffre C; Herrmann F; Hauw JJ
    Acta Neuropathol; 2002 May; 103(5):481-7. PubMed ID: 11935264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing the cognitive impact of Alzheimer disease pathology and vascular burden in the aging brain: the Geneva experience.
    Giannakopoulos P; Gold G; Kövari E; von Gunten A; Imhof A; Bouras C; Hof PR
    Acta Neuropathol; 2007 Jan; 113(1):1-12. PubMed ID: 17036244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is subcortical vascular dementia a clinical entity for clinical drug trials?
    Inzitari D; Erkinjuntti T; Wallin A; del Ser T; Pantoni L
    Alzheimer Dis Assoc Disord; 1999; 13 Suppl 3():S66-8. PubMed ID: 10609684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Towards defining the neuropathological substrates of vascular dementia.
    Kalaria RN; Kenny RA; Ballard CG; Perry R; Ince P; Polvikoski T
    J Neurol Sci; 2004 Nov; 226(1-2):75-80. PubMed ID: 15537525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subcortical ischemic vascular dementia.
    Chui HC
    Neurol Clin; 2007 Aug; 25(3):717-40, vi. PubMed ID: 17659187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroimaging of vascular dementia.
    Kanekar S; Poot JD
    Radiol Clin North Am; 2014 Mar; 52(2):383-401. PubMed ID: 24582345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical significance of white matter lesion in vascular dementia].
    Iwamoto T
    Nihon Ronen Igakkai Zasshi; 2001 Jul; 38(4):444-6. PubMed ID: 11523143
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.